France vs Singapore: Measles-containing-vaccine second-dose (MCV2) immunization coverage
France
93.0%
in 2025
Singapore
93.0%
in 2025
France rank
49th
Singapore rank
49th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- France
- Singapore
How they compare
France currently reports 93.0% against 93.0% in Singapore, a difference of 0.0%.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Singapore ahead.
France ranks 49th and Singapore ranks 49th of 194 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 96.1% | 96.1% | Singapore |
| 2010s | 76.0% | 91.8% | 15.8% | Singapore |
| 2020s | 92.3% | 92.8% | 0.5% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, France or Singapore?
- France, at 93.0% against 93.0% in Singapore as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between France and Singapore?
- 0.0%, with France ahead.
- How many years of comparable data are there for France and Singapore?
- 26 years are reported by both, from 2000 to 2025.
- How do France and Singapore rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- France ranks 49th and Singapore ranks 49th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.